Tag: CBT > Canada: Page 30

Finance

Village Farms Opts to Receive $5.94 Million Cash Refund from Pure Sunfarms

The refund relates to an additional equity contribution that Village Farms made to Pure Sunfarms on Nov. 19, 2019.

January 17, 2020

Finance

The Green Organic Dutchman Announces Executive Leadership Consolidation

The company is making changes to streamline its leadership structure.

January 9, 2020

Finance

Here Are the 12 Canadian Cannabis Companies That Trade on U.S. Stock Markets

FSD Pharma, a Toronto-based biotech pharmaceutical R&D company, garnered a Nasdaq uplisting this winter and began trading on the U.S. market Jan. 9.

January 9, 2020

Interviews & Opinion

Toronto-Based FSD Pharma Begins Trading on NASDAQ

The stock begins trading under the symbol ‘HUGE’ on Jan. 9, placing FSD Pharma in a select group of 12 Canadian-domiciled cannabis companies trading on the NYSE or NASDAQ.

January 9, 2020

Finance

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on Jan. 9, 2020

The company’s shares will continue to be listed on the Canadian Securities Exchange under the symbol ‘HUGE.’

January 7, 2020

Nevada

CES Wouldn’t Let a Cannabis Company Mention Cannabis on the Show Floor

The problem? Keep Labs’ team can’t mention “cannabis” while they’re exhibiting.

January 7, 2020

Finance

The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'

The company has announced a four-year extraction and white label agreement with Emerald Health Therapeutics Inc.

December 30, 2019

Canadian Cannabis Market

MJardin Awarded Cultivation and Processing License from Health Canada for its Largest Facility

The 120,000-square-foot retro-fitted cultivation facility located in Winnipeg, Manitoba, is the largest in the company’s portfolio.

December 19, 2019

Investors in the Cannabis Market

FSD Pharma Reports Third Quarter 2019 Financial Results

The company has also announced its intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA, during 1Q20.

December 17, 2019

Finance

DNA Genetics Announces Investment in the Company from Canopy Growth Co-Founder Bruce Linton

This investment in DNA will further strengthen the effort to bring the company’s award-winning genetics to new markets.

December 16, 2019

Finance

Aphria Inc. Announces $80 Million Financing of Aphria Diamond

The financing strengthens the company's balance sheet in support of long-term growth objectives without dilution to shareholders.

December 9, 2019

Finance

Aleafia Health Completes $7.1M Cannabis Sale Agreement

The transaction will include up to three shipments, all of which will be completed before Jan. 31, 2020.

December 9, 2019